NYSE · LLY
Eli Lilly and Company
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
Loading market information…
OTC · GTBIF · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Green Thumb Industries Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.35% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Green Thumb Industries Inc.’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of $0.03. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Green Thumb Industries Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Green Thumb Industries Inc. (GTI) is an American enterprise primarily involved in the production, distribution, and retail of diverse cannabis offerings throughout the United States, serving both medicinal and recreational consumers. Its extensive product catalog features raw cannabis flower, alongside a wide array of processed and packaged goods such as pre-rolls, concentrated extracts, vaporizers, liquid tinctures, edible treats, and topical applications. These items are marketed under notable brands including Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM. While GTI primarily supplies its merchandise to independent retail establishments, it also engages in direct-to-consumer sales via its proprietary network of stores. As of April 11, 2022, the company managed and operated 77 retail locations across the U.S. Established in 2014, Green Thumb Industries Inc. maintains its corporate headquarters in Chicago, Illinois.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 7, 2025 | $0.04-20.0% vs estimate | $279.54M-1.47% vs estimate |
|---|
| Q4 2024 | Feb 26, 2025 | $0.04-33.33% vs estimate | $294.32M+2.13% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | $0.04-33.33% vs estimate | $286.87M-0.23% vs estimate |
|---|
THE ANALYST VIEW
5 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 2 contributors · Median target $18.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
$275.20+$4.16 (+1.53%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 2.09% below the high.
$290.97+$4.98 (+1.74%)
AbbVie Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.55% below the high.
$410.91+$3.81 (+0.94%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 10.99% below the high.
$146.33+$5.40 (+3.83%)
Merck & Co., Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.75% below the high.
$0.53+$0.01 (+2.72%)
Jushi Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 41.69% below the high.
$0.34-$0.00 (-0.29%)
Grown Rogue International Inc.’s quoted price sits in the lower half of its reported 52-week range, 34.69% below the high.
CA$0.20CA$0.00 (0.0%)
Leef Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.46% below the high.
